Bausch Health Cos Price to Free Cash Flow Ratio 2010-2024 | BHC

Historical price to free cash flow ratio values for Bausch Health Cos (BHC) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bausch Health Cos Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-11-01 9.78 7.52
2024-09-30 8.16 $1.30 6.28
2024-06-30 6.97 $0.87 8.01
2023-12-31 8.02 $2.24 3.58
2023-09-30 8.22 $-1.53 0.00
2023-06-30 8.00 $-1.84 0.00
2023-03-31 8.10 $-5.94 0.00
2022-12-31 6.28 $-6.04 0.00
2024-03-31 10.61 $-3.38 0.00
2022-09-30 6.89 $-3.81 0.00
2022-06-30 8.36 $2.94 2.85
2022-03-31 22.85 $3.72 6.15
2021-12-31 27.61 $5.09 5.43
2021-09-30 27.85 $6.12 4.55
2021-06-30 29.32 $3.43 8.56
2021-03-31 31.74 $2.81 11.29
2020-12-31 20.80 $2.34 8.90
2020-09-30 15.54 $1.83 8.48
2020-06-30 18.29 $2.66 6.87
2020-03-31 15.50 $3.11 4.99
2019-12-31 29.92 $3.62 8.26
2019-09-30 21.85 $3.91 5.58
2019-06-30 25.22 $5.84 4.32
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00